ArticleDiscover oncology2025

METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells.

Bo Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.